As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year SAN FRANCISCO, CA, UNITED STATES, February 10, ...
As President Trump hails pricing agreements with the pharmaceutical industry, some biotech companies are worried they have been left out in the cold.
A group of European venture capital firms is banding together to try to improve the funding landscape for biotech startups.
The latest firm to top up its venture capital coffers is Austin, Texas-based Santé Ventures, which on Monday announced its ...
NINGBO, ZHEJIANG, CHINA, January 21, 2026 /EINPresswire.com/ -- Ningbo Scientz Biotechnology Co., Ltd., a leading ...
Zacks Investment Research on MSN
Moderna's shares climb 5.3% as investors revisit biotech leaders
Shares of Moderna, Inc. MRNA rose 5.3% on Friday, Feb. 13, as investors showed renewed interest in large-cap biotech names. The gain stood out against a choppy broader market, suggesting traders were ...
From Philly and the Pa. suburbs to South Jersey and Delaware, what would you like WHYY News to cover? Let us know! Philadelphia’s biotechnology industry is facing a wave of uncertainty, as several ...
The European pharmaceutical and biotechnology market offers vast opportunities. The European Pharmaceutical Directory aids businesses by providing up-to-date contact information, profiles, and ...
The European Directory of Biotechnology Companies offers key market opportunities by providing access to 2,000 biotech companies and 5,000 executives. It assists in pinpointing decision-makers, ...
Raise large amounts of capital with an initial public offering, burn cash while navigating clinical trials, then submit a new ...
The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results